Some Doctors Say They Won't Give Their Patients a Contentious New Alzheimer's Drug
Parts of the medical world are continuing to rebel against Aduhelm, the controversial treatment developed by Biogen and recently approved for Alzheimer's disease by the Food and Drug Administration. This week, two major medical centers in the U.S. said that they would not treat their patients with the drug.